Key result
Β-blocker therapy for 1 year improved LVEF, LVEDD, and MR in African Americans and Caucasians, but Hispanics showed no significant improvement in LVEDD and MR.
Why the study?
Does beta-blocker therapy improve left ventricular remodeling differently across ethnic groups in patients with systolic heart failure?
Cohort (n=418)
Does beta-blocker therapy improve left ventricular remodeling differently across ethnic groups in patients with systolic heart failure?
Beta-blocker therapy induces reverse remodeling in African Americans and Caucasians with systolic heart failure, but Hispanics may experience less improvement in left ventricular dimensions and mitral regurgitation.
Answers are grounded in this paper and cite their sources.
Ethnic differences may influence remodeling response to beta-blockers; leaves open validation in diverse HF cohorts.
BACKGROUND: Although β-blockers (BBs) have been shown to improve cardiac function, there is individual and ethnic variation in BB clinical response. We examined the effects of BBs on left ventricular remodeling among African Americans (AAs), Hispanics, and Caucasians with systolic heart failure. HYPOTHESIS: There is ethnic variability in the effects of BBs on cardiac remodeling. METHODS: There were 185 AAs, 159 Hispanics, and 74 Caucasians selected with ejection fraction ≤ 40% from any etiology. Change in left ventricular ejection fraction (LVEF), left ventricular end-diastolic dimensions (LVEDD), and degree of mitral regurgitation (MR) in response to 1 year of BBs was evaluated retrospectively. RESULTS: Overall, there was a significant improvement in LVEF, LVEDD, and degree of MR in AAs and Caucasians after 1 year of BBs (P < 0.001 vs baseline). Compared with other races, Hispanics (%) had no significant improvement in LVEDD and degree of MR, and had fewer patients with reverse remodeling: LVEF (42.77%), LVEDD (5.03%), and MR (16.35%). In multivariable analysis, Hispanic and AA race were important predictors of LVEF and LVEDD (P < 0.01) but not MR response. CONCLUSIONS: Although most patients demonstrated improvement of LVEF, there seems to be ethnic variability in the effects of BBs on cardiac remodeling. Degree of MR and LVEDD failed to show improvement among Hispanics.
No takes yet. Share an insight, caveat, or question.
Kelesidis et al. (2013) conducted a cohort in Systolic heart failure (n=418). β-blockers vs. Baseline (within-group) and between ethnic groups was evaluated on Change in left ventricular ejection fraction (LVEF), left ventricular end-diastolic dimensions (LVEDD), and degree of mitral regurgitation (MR) (p=<0.001). Β-blocker therapy for 1 year improved LVEF, LVEDD, and MR in African Americans and Caucasians, but Hispanics showed no significant improvement in LVEDD and MR.
Synapse has enriched 10 related papers. Consider them for comparative context: